PubMed:35351535 / 843-1051 JSONTXT

Annnotations TAB JSON ListView MergeView

    Inflammaging

    {"project":"Inflammaging","denotations":[{"id":"T10","span":{"begin":0,"end":208},"obj":"Sentence"},{"id":"T10","span":{"begin":0,"end":208},"obj":"Sentence"}],"text":"This randomized placebo-controlled trial included 80 type 1 diabetic patients with microvascular complications who were randomly divided to receive either 24 weeks of metformin 500 mg/day or matching placebo."}

    maxiaofeng52_800_3

    {"project":"maxiaofeng52_800_3","denotations":[{"id":"T7","span":{"begin":167,"end":176},"obj":"CI"},{"id":"T10","span":{"begin":53,"end":68},"obj":"DP"},{"id":"T13","span":{"begin":200,"end":207},"obj":"CI"},{"id":"T14","span":{"begin":16,"end":23},"obj":"CI"}],"text":"This randomized placebo-controlled trial included 80 type 1 diabetic patients with microvascular complications who were randomly divided to receive either 24 weeks of metformin 500 mg/day or matching placebo."}

    wangzhuo19_800_3

    {"project":"wangzhuo19_800_3","denotations":[{"id":"T15","span":{"begin":53,"end":68},"obj":"DP"},{"id":"T3","span":{"begin":167,"end":176},"obj":"CI"},{"id":"T6","span":{"begin":16,"end":23},"obj":"CI"},{"id":"T7","span":{"begin":200,"end":207},"obj":"CI"}],"text":"This randomized placebo-controlled trial included 80 type 1 diabetic patients with microvascular complications who were randomly divided to receive either 24 weeks of metformin 500 mg/day or matching placebo."}